US Earnings Financial Results SEC Filings — May 05, 2026

05-05-2026

Black Stone Minerals, L.P. reported Q1 2026 total revenue of $59,359 thousand, nearly flat YoY (+0.2%) from $59,252 thousand, with oil and condensate sales up 8% to $54,114 thousand and natural gas/NGL sales up 9% to $63,408 thousand, but offset by larger derivative losses of $64,550 thousand and a 7% drop in lease bonus income. Net income fell 17% YoY to $13,272 thousand from $15,948 thousand due to higher interest expense ($3,361 thousand vs $1,397 thousand) and slightly elevated operating expenses, resulting in net income attributable to common units of $5,906 thousand (down 31%) and EPS of $0.03 (vs $0.04). Operating cash flow was $62,560 thousand (down 4% YoY), while cash and equivalents rose to $11,612 thousand from $1,478 thousand QoQ amid borrowings and lower distributions.

• ·Credit facility increased to $187,000 thousand from $154,000 thousand QoQ.
• ·Commodity derivative liabilities net $36,188 thousand as of March 31, 2026 (current $27,624 thousand, long-term $8,564 thousand).
• ·Common unit distributions reduced to $0.30 per unit from $0.375 per unit YoY.
• ·Weighted average common units outstanding (basic) 212,369 in Q1 2026 vs 211,253 in Q1 2025.

05-05-2026

DigitalOcean Holdings, Inc. reported Q1 2026 revenue of $257,905 thousand, up 22% YoY from $210,703 thousand, with gross profit increasing 12% to $144,710 thousand. However, operating income dipped 3% YoY to $36,571 thousand amid 18% higher operating expenses, and net income declined sharply 59% to $15,771 thousand due to elevated interest expense of $10,553 thousand and a $2,700 thousand loss on debt extinguishment. The balance sheet strengthened significantly with cash and equivalents rising to $741,363 thousand from $254,475 thousand QoQ, and stockholders' equity flipping to a positive $887,376 thousand from a $28,690 thousand deficit, bolstered by $887,888 thousand net proceeds from a follow-on public offering.

• ·Accounts receivable increased to $105,456 thousand from $90,908 thousand QoQ.
• ·Debt, current portion decreased to $311,256 thousand from $325,109 thousand QoQ, while long-term debt fell to $608,466 thousand from $970,653 thousand.
• ·Capital expenditures on property and equipment were $39,992 thousand in Q1 2026, down from $61,963 thousand YoY.
• ·Weighted-average diluted shares used for EPS increased to 111,915 thousand from 102,322 thousand YoY.

05-05-2026

05-05-2026

05-05-2026

Gartner Inc reported Q1 2026 total revenues of $1,511,041 thousand, down 1.5% YoY to $1,534,130 thousand, primarily due to a 14.7% decline in Consulting to $119,129 thousand and a 70.7% drop in Other to $19,392 thousand, despite 3.1% growth in Insights to $1,294,195 thousand and 7.8% rise in Conferences to $78,325 thousand. Operating income increased 13.7% to $316,092 thousand and net income rose 5.4% to $222,344 thousand with diluted EPS up 17.3% to $3.18. Stockholders' equity fell sharply to $63,384 thousand from $319,908 thousand at December 31, 2025, driven by $534,637 thousand in share repurchases.

• ·Operating cash flow increased 24.8% YoY to $391,039 thousand.
• ·Proceeds from sale of divested operation: $104,798 thousand, with gain of $6,138 thousand.
• ·Total assets decreased to $7,655,273 thousand from $8,085,400 thousand at Dec 31, 2025.
• ·Fees receivable, net decreased to $1,411,496 thousand from $1,684,522 thousand at Dec 31, 2025.

05-05-2026

Eve Holding, Inc. reported a widened net loss of $68,813 for the three months ended March 31, 2026, up 41% YoY from $48,784, primarily due to R&D expenses rising 32% to $59,077 while SG&A expenses declined slightly to $7,247. Cash and cash equivalents increased 17% QoQ to $120,943, supported by $117,062 in financing inflows mainly from new debt, but total equity dropped sharply 55% QoQ to $56,054 amid higher long-term debt of $295,820. Operating cash use intensified to $68,113 from $24,878 YoY.

• ·Financial investments increased to $311,629 as of Mar 31 2026 from $280,845 Dec 31 2025.
• ·Net cash provided by financing activities was $117,062 in Q1 2026, driven by $167,919 proceeds from debt offset by $50,736 repayments.
• ·Gain from warrant liability was $598 in Q1 2026, down from $3,315 YoY.

05-05-2026

For the three months ended March 31, 2026, net income rose 45% YoY to $291 million, supported by a 5% increase in net interest income to $552 million, significantly lower provision for credit losses ($48 million vs $118 million), and 5% higher other revenues at $544 million. However, total interest income declined 10% YoY to $1,696 million due to drops in loan interest (-9%) and short-term investments (-35%), operating expenses edged up 1% to $669 million, and comprehensive income fell 28% to $226 million. Total assets expanded 1% QoQ to $174.7 billion, though deposits decreased 2% to $121.5 billion.

• ·Net cash provided by operating activities increased to $1,439M from $817M YoY.
• ·Net cash used in investing activities was $890M vs provided $2,441M YoY.
• ·Loans grew 3% QoQ to $61,586M gross.
• ·Allowance for credit losses rose to $481M from $442M QoQ.

05-05-2026

Avery Dennison Corp reported Q1 2026 net sales of $2,298.5 million, up 7.0% YoY from $2,148.3 million, driven by higher volumes, while net income rose modestly 1.1% to $168.1 million from $166.3 million with EPS at $2.19 versus $2.10. Gross margin held flat at 28.9% YoY amid higher cost of products sold, but marketing, general, and administrative expenses increased 8.2% to $375.1 million. Operating cash flow turned strongly positive at $136.5 million, compared to a $16.3 million use in Q1 2025.

• ·Share repurchases totaled $60.6 million in Q1 2026, down from $261.6 million in Q1 2025.
• ·Dividends paid increased to $72.3 million from $69.4 million YoY.
• ·Capital expenditures on property, plant and equipment were $28.3 million, down from $36.0 million YoY.
• ·Total shareholders' equity rose to $2,300.5 million from $2,242.1 million QoQ.

05-05-2026

Avista Corp reported net income of $92M for Q1 2026, up 16% YoY from $79M, with income from operations rising 7% to $134M due to significantly lower operating expenses ($436M vs $492M). However, total operating revenues declined 8% to $570M from $617M, driven by lower utility revenues excluding alternative programs ($547M vs $625M). Operating cash flow was slightly down to $179M from $184M, while capital expenditures increased to $150M from $103M.

• ·Total assets grew to $8,408M as of March 31, 2026 from $8,359M at December 31, 2025.
• ·Short-term borrowings decreased to $385M from $388M.
• ·Shareholders’ equity increased to $2,776M from $2,709M.
• ·Dividends declared per common share $0.493 in Q1 2026 vs $0.490 in Q1 2025.

05-05-2026

Oaktree Specialty Lending Corp (OCSL) reported a decline in total investments to $2,766,367 from $2,847,782 as of September 30, 2025, with net assets decreasing to $1,382,064 ($15.69 per share) from $1,465,813 ($16.64 per share), reflecting a 5.7% QoQ drop amid net unrealized depreciation of $39,338 for the quarter. For the six months ended March 31, 2026, total investment income fell 11.4% YoY to $145,481 from $164,215, and net investment income declined 14.8% to $71,065 from $83,357; however, net decrease in net assets from operations improved to ($13,281) from ($29,010) YoY due to reduced unrealized losses.

• ·Net investment income per common share for six months ended March 31, 2026: $0.81 (down from $0.99 YoY)
• ·Earnings per common share for six months: ($0.15) (improved from ($0.35) YoY)
• ·Cash and cash equivalents decreased to $51,261 from $79,630 QoQ
• ·Distributions to stockholders for six months: $70,468
• ·Non-control/Non-affiliate investments cost: $2,611,720 as of March 31, 2026 (179.6% of net assets)

05-05-2026

Eloxx Pharmaceuticals reported a widened net loss of $3,754 thousand for the three months ended March 31, 2026, compared to $1,709 thousand in the prior year period, driven by significantly higher operating expenses including research and development at $1,659 thousand (up from $510 thousand) and general and administrative at $2,136 thousand (up from $712 thousand). Cash and cash equivalents increased to $6,363 thousand from $4,785 thousand at December 31, 2025, supported by $7,031 thousand in net financing proceeds primarily from pre-funded warrants. However, net cash used in operating activities rose sharply to $5,453 thousand from cash provided of $1,204 thousand in the prior year, indicating elevated cash burn.

• ·Weighted average shares used in net loss per share increased to 48,210,071 in Q1 2026 from 3,805,550 in Q1 2025.
• ·Warrants outstanding increased to 55,102,631 as of March 31, 2026 from 38,776,102 at December 31, 2025.
• ·Domicilium debt conversion: principal of $1,000 and accrued interest of $56 converted to pre-funded warrants.
• ·Stockholders’ deficit improved to $(7,584) thousand from $(11,907) thousand.

05-05-2026

Sonos reported Q2 FY2026 revenue of $281.5M, up 8.5% YoY from $259.8M, with gross profit rising 9.7% to $124.6M and operating expenses declining 10.6% to $156.2M, narrowing the net loss to $28.9M from $70.1M. For the six months ended March 28, 2026, revenue grew modestly 2.0% YoY to $827.2M, achieving net income of $64.9M versus a prior-year loss of $19.9M, though Q2 remained unprofitable. Cash and equivalents increased to $200.2M from $174.7M at fiscal year-end, supported by $98.0M in operating cash flow, flat YoY.

• ·EMEA revenue up 20.9% YoY to $83.2M in Q2 FY2026, Americas up 2.1% to $180.6M, APAC up 25.4% to $17.8M.
• ·Company repurchased $65.1M in common stock during six months FY2026.
• ·Inventories decreased to $160.8M from $171.0M year-to-date.
• ·Net cash used in investing activities $6.8M in six months FY2026, improved from $17.2M prior year.

05-05-2026

Paymentus Holdings, Inc. reported strong Q1 2026 results with revenue of $358,441 up 30% YoY from $275,235, gross profit up 31% to $86,232, operating income up 69% to $26,552, and net income up 51% to $20,881. Payment transaction processing revenue, the primary driver, grew 30% YoY to $355,664. However, cash provided by operating activities declined 40% YoY to $30,452 due to a $15M increase in accounts receivable, and total operating expenses rose 19% YoY to $59,680.

• ·Accounts and other receivables increased $14.9M QoQ to $117,213.
• ·Stock-based compensation expense $5,694, up from prior periods.
• ·Property and equipment, net declined to $790 from $877 QoQ.
• ·Cash paid for income taxes, net of refunds: $141.

05-05-2026

For the six months ended March 31, 2026, TVA reported total operating revenues of $6,595M, up 2.2% YoY from $6,452M, with operating income increasing 12.1% to $1,266M and net income rising 23.5% to $658M, driven by lower operating and maintenance expenses. However, for the three months ended March 31, 2026, revenues grew only 0.4% to $3,546M while net income declined 3.9% to $392M YoY, and cash and cash equivalents dropped sharply 68% to $501M from $1,576M as of September 30, 2025 amid higher construction spending and debt redemptions.

• ·Fuel expenses increased 17.6% YoY to $683M for three months ended March 31, 2026.
• ·Net cash from operating activities declined 24.4% YoY to $1,106M for six months ended March 31, 2026.
• ·Construction expenditures were $1,996M for six months ended March 31, 2026, down from $2,396M YoY.

05-05-2026

Duolingo reported Q1 2026 revenues of $291,967 thousand, up 26.6% YoY from $230,743 thousand, with gross profit increasing 29.9% to $213,096 thousand and operating income nearly doubling 88.8% to $44,527 thousand. Net income rose 23.7% YoY to $43,460 thousand, supported by strong cash flow from operations of $150,771 thousand (up 42.6% YoY), though sales and marketing expenses surged 47.2% to $39,249 thousand. Total assets grew 3.3% QoQ to $2,057,994 thousand as of March 31, 2026, with $25,830 thousand in common stock repurchases.

• ·Deferred revenues increased to $513,256 thousand as of Mar 31 2026 from $496,205 thousand at Dec 31 2025.
• ·Stock-based compensation expense was $34,647 thousand in Q1 2026, up from $31,018 thousand in Q1 2025.
• ·Common stock repurchases totaled $25,830 thousand with 262 shares repurchased in Q1 2026.

05-05-2026

05-05-2026

Vivid Seats reported Q1 2026 revenues of $125,783, down 23.3% YoY from $164,023, with all segments declining: Marketplace -27.1% to $97,526, Owned Properties -18.7% to $88,714, and Private Label Offering -64.0% to $8,812; net loss widened to $14,631 from $9,788. While operating loss increased to $8,788 from $4,321 and total liabilities rose to $787,127 from $721,995 QoQ, the company generated strong operating cash flow of $46,007 versus a $25,288 outflow YoY, increasing cash and equivalents to $143,555 from $102,702 QoQ.

• ·Depreciation and amortization increased 5.9% YoY to $12,308.
• ·Equity-based compensation expense declined to $4,414 from $10,751 YoY.
• ·Weighted average basic Class A shares outstanding: 10,815,704 vs 6,645,011 YoY.
• ·Cash paid for interest: $6,153 vs $7,749 YoY.

05-05-2026

For the three months ended March 31, 2026, Life Time Group Holdings, Inc. reported total revenue of $788,700, up 11.7% YoY from $706,041, with center revenue increasing 11.8% to $767,566, and net income rising 15.7% to $88,098. However, operating expenses grew 9.3% to $653,862, capital expenditures surged 82.6% to $260,016, leading to a $81,986 decrease in cash and cash equivalents. Total equity expanded to $3,219,271, supported by net income and share-based compensation.

• ·Diluted EPS increased to $0.39 from $0.34 YoY.
• ·Interest expense improved to $(15,697) from $(25,107), reducing total other expense.
• ·Share repurchases of $10,702 in Q1 2026.
• ·Weighted-average diluted shares outstanding: 227,454 (Q1 2026) vs 223,619 (Q1 2025).

05-05-2026

EVgo Inc. reported Q1 2026 total revenue of $109.5M, up 45.5% YoY from $75.3M, driven by strong growth in non-charging network revenue (eXtend +41%, AV and ancillary +338%). However, operating loss widened 8.8% YoY to $36.3M, net loss increased 41% to $36.9M, and net cash used in operating activities surged to $35.4M from $10.2M, contributing to a QoQ decline in cash and equivalents to $122.4M.

• ·Capital expenditures increased to $30.6M in Q1 2026 from $15.0M YoY.
• ·Redeemable noncontrolling interest decreased to $313.9M from $502.8M QoQ.
• ·Stockholders’ equity improved to $38.7M from a $116.9M deficit QoQ, driven by $168.4M redeemable noncontrolling interest adjustment.

05-05-2026

Viridian Therapeutics reported total revenues of $141 thousand for Q1 2026, up 96% YoY from $72 thousand, primarily from collaboration revenue with related parties. However, operating expenses increased 24% YoY to $116,310 thousand, driven by a 126% rise in SG&A to $38,679 thousand, resulting in a widened net loss of $104,901 thousand (21% worse YoY) and higher cash burn from operations at $119,654 thousand. Cash and equivalents declined 17% QoQ to $176,346 thousand from $212,382 thousand, with total assets down 12% to $789,017 thousand.

• ·Weighted-average common shares outstanding Q1 2026: 102,211,657 (up from 81,344,134 YoY)
• ·Derivative liability decreased to $12,500 thousand from $20,030 thousand QoQ due to $7,530 thousand fair value gain
• ·Liability related to sale of future revenue increased to $36,092 thousand from $34,244 thousand
• ·Share-based compensation expense: $13,390 thousand in Q1 2026 (up from $10,220 thousand YoY)

05-05-2026

CPI Card Group Inc. reported Q1 2026 revenue of $147,108 thousand, up 19.9% YoY from $122,761 thousand, with gross profit increasing 8.4% to $44,124 thousand. However, income from operations declined 22.0% to $10,994 thousand due to a 24.6% rise in SG&A expenses to $33,130 thousand, resulting in net income of $2,056 thousand versus $4,774 thousand in Q1 2025. Balance sheet showed total assets decreasing to $386,454 thousand from $403,191 thousand at year-end 2025, with long-term debt reduced to $276,903 thousand.

• ·Operating cash flow improved to $13,648 thousand from $5,593 thousand YoY.
• ·Capital expenditures decreased to $3,513 thousand from $5,301 thousand YoY.
• ·Interest paid was $14,332 thousand in Q1 2026 versus $14,998 thousand in Q1 2025.
• ·Basic EPS declined to $0.18 from $0.42 YoY.

05-05-2026

Total revenues grew 17.2% YoY to $330,959 thousand for the thirteen weeks ended March 29, 2026, driven by 17.4% higher restaurant sales to $328,148 thousand. However, income from operations declined 10.2% to $999 thousand amid higher costs including 32.2% rise in G&A to $39,945 thousand and 29.2% increase in depreciation to $21,396 thousand, resulting in a wider net loss of $2,685 thousand versus $829 thousand prior year. Net cash provided by operating activities improved sharply 71.1% to $34,456 thousand, while capital expenditures decreased to $29,346 thousand from $36,544 thousand.

• ·Restaurant sales breakdown: In-restaurant dining $265,722 thousand, third-party delivery $39,692 thousand, take-out $22,734 thousand for Q1 2026.
• ·Interest expense increased to $4,778 thousand from $3,334 thousand YoY.
• ·Deferred gift card revenue decreased to $4,092 thousand as of March 29, 2026 from $6,548 thousand at December 28, 2025.
• ·Net cash used in investing activities improved to $29,532 thousand from $36,605 thousand YoY.

05-05-2026

Orthofix Medical Inc. reported Q1 2026 net sales of $196,708 thousand, up 1.6% YoY from $193,646 thousand, driven by lower cost of sales which fell 20.6% to $57,162 thousand, leading to gross profit of $139,546 thousand (+14.7% YoY). However, SG&A expenses rose slightly to $134,911 thousand and the company recorded an operating loss of $14,436 thousand (improved 70.5% from $48,873 thousand YoY) and net loss of $20,908 thousand, with long-term debt increasing to $221,335 thousand from $157,391 thousand at year-end. Cash and equivalents grew to $120,278 thousand, supported by $64,025 thousand in credit facility proceeds, though operating cash flow remained negative at $17,610 thousand.

• ·Inventories increased to $177,818 thousand as of March 31, 2026 from $172,319 thousand at December 31, 2025.
• ·Operating cash flow used $17,610 thousand in Q1 2026, slightly improved from $18,391 thousand in Q1 2025.
• ·Capital expenditures were $10,661 thousand in Q1 2026, up from $6,736 thousand YoY.
• ·Shareholders' equity decreased to $435,186 thousand from $450,037 thousand at year-end.

05-05-2026

Pfizer's total revenues increased 5% YoY to $14,451 million in Q1 2026 from $13,715 million, with alliance revenues up 11% to $2,339 million and royalty revenues up 29% to $396 million, while product revenues grew modestly 4% to $11,715 million. However, net income attributable to Pfizer shareholders declined 9% to $2,687 million from $2,967 million, and diluted EPS fell to $0.47 from $0.52, driven by a 25% rise in cost of sales to $3,548 million and 13% higher R&D expenses at $2,490 million, despite lower selling expenses and restructuring costs. Total assets stood at $207,618 million, with shareholders' equity rising to $90,101 million.

• ·Cash and cash equivalents increased to $1,703 million from $1,142 million at year-end 2025.
• ·Long-term debt decreased to $60,565 million from $61,641 million at year-end 2025.
• ·Net cash from investing activities was $785 million, down from $3,274 million due to absence of Haleon sale proceeds.
• ·Accrued rebates and other sales-related accruals slightly decreased to $11,550 million from $11,666 million at year-end.

05-05-2026

Pediatrix Medical Group reported Q1 2026 net revenue of $476,196, up 3.8% YoY from $458,359, driven by 4.1% growth in net patient service revenue to $405,352 and 7.3% increase in hospital contract fees to $69,920; however, other revenue declined sharply 75.6% to $924, and net cash used in operating activities worsened to $(129,847) from $(117,463). Net income rose 42.6% YoY to $29,572 with operating income up 29.8% to $41,657, though cash and equivalents dropped 45.2% QoQ to $205,780 amid $21,451 in share repurchases.

• ·Total assets declined 7.8% QoQ to $2,070,295 from $2,246,696.
• ·Shareholders’ equity increased 1.5% QoQ to $878,576.
• ·Goodwill increased $7,516 due to acquisition.
• ·Transformational and restructuring expenses declined 25.5% YoY to $4,922.

05-05-2026

TopBuild Corp reported Q1 2026 net sales of $1,445,860, up 17.2% YoY from $1,233,278, driven by 31.7% growth in Specialty Distribution to $737,080 and 59.0% surge in Commercial/Industrial sales to $736,761; however, net income declined 15.1% YoY to $104,813 from $123,385 due to higher SG&A expenses (up 29.4% to $225,210) and interest expense (up 120.6% to $36,623), with operating profit slightly down 1.4% to $175,043 and Residential sales falling 8.0% to $709,099. Cash from operations rose 5.3% to $160,736, supported by acquisitions of $27,888, while total debt decreased slightly to $2,832,388 from year-end levels.

• ·Weighted average basic shares outstanding decreased to 27,976,514 from 29,028,234 YoY due to repurchases.
• ·Goodwill increased to $3,070,940 from $3,045,227 QoQ, reflecting acquisitions.
• ·Net leverage ratio and secured leverage ratio defined under Credit Agreement, with recent Amendment No. 5 on May 16, 2025.

05-05-2026

Shopify Inc. reported Q1 2026 total revenues of 3,170 up 34% YoY from 2,360, with Merchant solutions growing 39% to 2,420 and Subscription solutions up 21% to 750, driving gross profit up 32% to 1,546 and operating income up 88% to 382. However, a 1,064 unrealized loss on equity and other investments contributed to a net loss of 581, improved from 682 YoY but still substantial, while total assets declined 7% QoQ to 14,121 from 15,189 and shareholders' equity fell to 12,501 from 13,473. Operating cash flow increased 31% YoQ to 481.

• ·Weighted average basic shares: 1,303,357,874 Q1 2026 vs 1,295,377,376 Q1 2025.
• ·Cash and cash equivalents increased to 1,848 from 1,545 QoQ.
• ·Marketable securities decreased to 3,895 from 4,233 QoQ.
• ·Common stock repurchased: 4,214,019 shares for 521.

05-05-2026

uniQure N.V. reported Q1 2026 license revenues of $3.6M, up 127% YoY from $1.6M, driven by higher recognition, while R&D expenses decreased 19% YoY to $29.2M. However, net loss widened 23% YoY to $53.5M due to an 84% surge in SG&A to $20.1M and higher interest expense; total assets declined 6% QoQ to $779M with shareholders' equity dropping 25% QoQ to $149M amid ongoing cash burn. Cash and equivalents rose 74% QoQ to $140M, bolstered by $99M in investment maturities, though operating cash use improved only modestly YoY to $38M.

• ·Current investment securities declined 18% QoQ to $447M from $542M.
• ·Liability from royalty financing agreement increased to $482M from $473M QoQ.
• ·Interest expense rose slightly to $14M YoY from $15.1M (actually decreased but still high).

05-05-2026

Fabrinet reported strong Q3 FY26 results with revenues of $1,214,293 thousand, up 39.3% YoY from $871,799 thousand, net income of $125,213 thousand, up 54.0% YoY, and diluted EPS of $3.45, up 53.3% YoY. For the nine months ended March 27, 2026, revenues reached $3,325,309 thousand, up 32.5% YoY, and net income $333,767 thousand, up 36.1% YoY. However, net cash from operating activities declined 26.1% YoY to $201,758 thousand for the nine months, driven by sharp increases in trade accounts receivable (up $150M) and inventories (up $297M).

• ·Gross profit margin improved slightly to 11.9% in Q3 FY26 from 11.7% YoY.
• ·North America revenue represented 52.1% of Q3 total ($633,029 thousand), up from 47.7% for nine months.
• ·Asia-Pacific and others revenue at 37.4% of Q3 total ($453,881 thousand), down from 42.3% for nine months.
• ·Europe revenue stable at 10.5% of Q3 total ($127,383 thousand).
• ·Inventories increased to $875,988 thousand as of March 27, 2026 from $581,015 thousand at June 27, 2025.
• ·Trade accounts receivable rose to $908,544 thousand from $758,894 thousand.

05-05-2026

Q32 Bio Inc. reported a narrower net loss of $7.6M for Q1 2026 compared to $11.0M in Q1 2025, driven by significant YoY reductions in R&D expenses (down 55% to $3.2M) and G&A expenses (down 12% to $4.5M). Cash and equivalents increased to $50.8M as of March 31, 2026 from $48.3M at year-end 2025, bolstered by $10.4M net proceeds from a registered direct offering. However, the company continues to burn cash with $6.3M used in operations and remains unprofitable with total stockholders' equity at $46.3M.

• ·Net cash used in operating activities improved to $6.3M in Q1 2026 from $12.5M in Q1 2025.
• ·Venture debt current portion $6.2M as of March 31, 2026.
• ·Weighted-average common shares basic and diluted: 14,095,371 in Q1 2026 vs 12,197,615 in Q1 2025.
• ·Net loss per share basic and diluted: $(0.54) in Q1 2026 vs $(0.90) in Q1 2025.

05-05-2026

Ocular Therapeutix reported Q1 2026 total revenue of $10,785, up slightly 0.8% YoY from $10,698, driven by product revenue growth from $10,634 to $10,785; however, collaboration revenue fell to $0 from $64, and operating expenses surged 39.5% to $104,125, leading to a widened net loss of $88,612 from $64,053. Cash and equivalents declined to $666,699 from $737,060 at year-end 2025 amid higher cash burn of $65,993 in operations versus $44,671 YoY.

• ·R&D expenses increased to $66,213 in Q1 2026 from $42,857 YoY.
• ·Stock-based compensation expense was $15,582 in Q1 2026.
• ·Deferred revenue remained flat at $14,000.
• ·Notes payable, net at $72,062 as of March 31, 2026.

05-05-2026

Palladyne AI Corp. reported Q1 2026 revenue of $3,538 thousand, more than doubling YoY from $1,710 thousand, with new product revenue of $1,691 thousand and engineering services revenue of $1,780 thousand offsetting a decline in product development contract revenue to $67 thousand. However, the company incurred a net loss of $12,608 thousand versus net income of $22,759 thousand in Q1 2025, driven by higher operating expenses of $15,457 thousand (up 79% YoY) and a $1,046 thousand loss on warrant liabilities compared to a $29,248 thousand gain prior year. Total assets declined 3% QoQ to $92,552 thousand, with cash and equivalents at $17,854 thousand (down slightly QoQ) and net cash used in operations at $10,239 thousand.

• ·Net cash used in operating activities increased to $10,239 thousand in Q1 2026 from $7,516 thousand in Q1 2025.
• ·Marketable securities decreased QoQ to $25,824 thousand from $28,836 thousand.
• ·Accrued liabilities increased QoQ to $4,273 thousand from $3,550 thousand.
• ·Stock-based compensation expense was $1,239 thousand in Q1 2026.
• ·Deferred revenue (current) increased to $591 thousand as of March 31, 2026 from $319 thousand as of Dec 31, 2025.

05-05-2026

Revenue increased 75% YoY to $140,557, gross profit rose 46% to $41,010, and income from operations grew 79% to $7,718 for Q1 2026. However, a $5,250 litigation settlement expense contributed to a net loss of $297, nearly flat with prior year's $282 loss, while net cash from operating activities swung to a $41,448 use of cash primarily due to a $69,633 inventory buildup. Total stockholders' equity edged up to $601,646 from $599,973 at year-end 2025.

• ·Customer A: 18.8% of Q1 2026 revenue and 18.8% of accounts receivable (down from 20.1% revenue YoY)
• ·Customer B: 13.1% of Q1 2026 revenue (down from 17.2% YoY)
• ·Net accounts receivable stable at $129,205 as of March 31, 2026 vs. $128,793 at December 31, 2025
• ·Cash and cash equivalents declined to $1,877 at March 31, 2026 from $7,320 at December 31, 2025
• ·Proceeds from revolving credit facility: $45,000 in Q1 2026

05-05-2026

For Q1 2026, Precision BioSciences reported revenue of $10,838 thousand, a massive increase from $29 thousand YoY, while operating expenses declined 10% to $19,913 thousand, narrowing the operating loss to $9,075 thousand from $22,112 thousand. However, net loss widened slightly to $18,441 thousand from $20,565 thousand YoY due to a $7,107 thousand loss on warrant liability fair value changes, cash and equivalents decreased QoQ to $99,370 thousand from $110,823 thousand, and stockholders' equity fell to $76,101 thousand from $92,248 thousand.

• ·Net cash used in operating activities improved to $11,937 thousand from $19,052 thousand YoY.
• ·Warrant liability increased to $22,802 thousand as of March 31, 2026 from $15,695 thousand as of December 31, 2025.
• ·Basic and diluted net loss per share improved to $(0.75) from $(2.21) YoY.
• ·PBGENE-HBV external development costs: $1,835 thousand (up from $1,601 thousand YoY); PBGENE-DMD: $3,998 thousand (up from $2,438 thousand YoY).

05-05-2026

Amalgamated Financial Corp. reported Q1 2026 net income of $25,223 thousand (up 0.8% YoY from $25,028 thousand), with net interest income growing 13.5% YoY to $80,156 thousand on higher loan ($63,471 thousand) and securities ($44,189 thousand) income. However, provision for credit losses surged to $13,488 thousand from $596 thousand, causing net interest income after provision to decline 4.7% YoY to $66,668 thousand, while non-interest expense rose 10.2% to $45,888 thousand. Total assets expanded 3.4% QoQ to $9,170,892 thousand, driven by 1.3% QoQ growth in net loans receivable to $4,965,203 thousand and 2.9% QoQ increase in deposits to $8,178,084 thousand.

• ·Earnings per common share - basic: $0.85 (Q1 2026) vs $0.82 (Q1 2025)
• ·Dividends declared: $0.17 per share (Q1 2026) vs $0.14 per share (Q1 2025)
• ·Net cash used in investing activities: $387,352 thousand (Q1 2026) vs $6,611 thousand (Q1 2025)
• ·Accumulated other comprehensive loss increased to $(36,586) thousand from $(32,088) thousand QoQ

05-05-2026

Ameresco reported Q1 2026 revenues of $401.5M, up 13.8% YoY from $352.8M, driven by higher project activity, with gross profit increasing 8.8% to $56.5M. However, operating income declined 25.2% to $10.2M due to elevated SG&A expenses and interest costs, leading to a widened net loss attributable to common shareholders of $18.3M or $(0.35) per share versus $5.5M or $(0.10) in Q1 2025. Cash flows from operations improved sharply to $35.4M from a negative $28.3M YoY, while total assets grew 2.3% QoQ to $4.6B.

• ·Energy assets, net increased to $2,155,837 thousand as of March 31, 2026 from $2,081,224 thousand as of December 31, 2025.
• ·Long-term debt and financing lease liabilities, net increased to $1,824,531 thousand as of March 31, 2026 from $1,749,708 thousand as of December 31, 2025.
• ·Stockholders’ equity decreased to $1,109,969 thousand as of March 31, 2026 from $1,122,816 thousand as of December 31, 2025.

05-05-2026

Ichor Holdings reported Q1 FY2026 net sales of $256.1M, up 4.7% YoY from $244.5M, with gross profit rising 13.1% to $32.3M and operating income turning positive at $2.1M versus a $1.2M loss prior year. However, the company posted a net loss of $2.5M (improved from $4.6M YoY), operating cash flow swung to negative $2.9M from $19.0M, and cash balances declined to $89.1M from $98.3M QoQ and $109.3M YoY.

• ·Capital expenditures decreased to $7.1M in Q1 FY2026 from $18.5M YoY.
• ·Accounts receivable increased $22.6M QoQ due to higher sales.
• ·Share-based compensation expense was $3.8M in Q1 FY2026, down slightly from $4.1M YoY.

05-05-2026

Tompkins Financial Corp (TMP) reported Q1 2026 net income of $26,074 thousand, up 32.6% YoY from $19,679 thousand, fueled by net interest income growth of 26.8% to $71,861 thousand and a reduced provision for credit losses to $1,502 thousand from $5,287 thousand. However, noninterest income plummeted 52.7% to $11,834 thousand from $25,032 thousand, primarily due to zero insurance commissions versus $11,599 thousand prior year, while comprehensive income fell to $19,030 thousand from $35,961 thousand on unrealized securities losses. Total assets edged up 0.3% QoQ to $8,695,761 thousand, with net loans increasing 0.5% to $6,419,835 thousand and deposits rising 1.7% to $7,054,172 thousand.

• ·Basic EPS $1.83 in Q1 2026 vs $1.38 in Q1 2025
• ·Diluted EPS $1.82 in Q1 2026 vs $1.37 in Q1 2025
• ·Cash dividends declared $0.67 per share in Q1 2026 vs $0.62 in Q1 2025
• ·Common stock repurchased 23,731 shares in Q1 2026 for $1,816 thousand
• ·Provision for credit losses $1,502 thousand in Q1 2026 vs $5,287 thousand in Q1 2025

05-05-2026

KBR reported first quarter 2026 revenues of $1,923 million, down 5% YoY from $2,018 million, with gross profit declining 12% to $265 million and operating income falling 11% to $180 million. Net income attributable to KBR decreased 12% to $102 million from $116 million, with diluted EPS of $0.80 versus $0.88. However, equity in earnings of unconsolidated affiliates rose 21% to $51 million, and cash flows from operating activities in continuing operations improved 21% to $110 million.

• ·Cash and cash equivalents decreased to $380 million from $500 million QoQ.
• ·Total assets increased slightly to $6,625 million from $6,584 million QoQ.
• ·Long-term debt at $2,534 million as of April 3, 2026.
• ·Cash dividends declared per share remained flat at $0.165.
• ·Basic weighted average shares outstanding declined to 127 million from 132 million YoY.

05-05-2026

Sharing Economy International Inc. (SEII) reported no revenues for the three and nine months ended September 30, 2024, resulting in a net loss of $17,973 for Q3 (vs. $15,846 loss in 2023) and $72,240 for the nine months (vs. $25.6M net income in 2023, driven by absence of $26.2M gain on subsidiary disposal). While operating expenses declined sharply 90% YoY to $59,610 for nine months and cash increased 163% to $4,087, total assets dipped slightly to $18,064,205 and stockholders' equity to $14,095,177. Balance sheet remains stable with minimal changes in related party balances.

• ·No interest or tax payments in cash flow statement for nine months ended Sep 30, 2024.
• ·Convertible note payable unchanged at $1,031,775.
• ·Foreign exchange loss of $12,472 in Q3 2024 vs. $2,026 loss in Q3 2023.

05-05-2026

For the three months ended March 31, 2026, M&T Bank Corp reported net income of $664 million, up 14% YoY from $584 million, with net interest income increasing 3% to $1,752 million and diluted EPS rising to $4.13 from $3.32. However, total deposits declined 2% QoQ to $163,741 million, shareholders' equity fell 4% to $27,972 million amid $400 million Series G preferred stock redemption and $1,250 million treasury stock purchases, and comprehensive income dropped sharply 46% YoY to $453 million due to $211 million other comprehensive loss.

• ·Net cash from operating activities increased to $1,012 million from $635 million YoY.
• ·Net cash from investing activities was a larger outflow of $4,324 million vs $349 million YoY.
• ·Fair value accounting election for residential mortgage loan servicing right assets added $197 million to retained earnings.
• ·Average basic common shares outstanding decreased to 149,225 thousand from 164,209 thousand YoY.

05-05-2026

AGCO Corporation reported robust Q1 2026 financial results, with net sales rising 14.3% YoY to $2,342.9M and net income attributable to AGCO surging over 423% to $55.0M from $10.5M, driven by higher gross profit and operating income of $80.7M (up 63.4% YoY). However, cash flow from operations deteriorated sharply, using $410.4M compared to $212.2M in Q1 2025, due to a $284.1M inventory build-up and $177.1M increase in receivables, resulting in cash and equivalents dropping 40.3% QoQ to $514.9M. Total assets grew modestly 0.9% QoQ to $12,040.9M, but current borrowings rose significantly to $555.5M.

• ·Diluted EPS attributable to AGCO $0.76 in Q1 2026 vs $0.14 in Q1 2025.
• ·Cash dividends declared and paid per common share remained flat at $0.29.
• ·Restructuring and business optimization expenses decreased to $10.0M from $13.0M YoY.
• ·Equity in net earnings of affiliates increased to $18.0M from $12.1M YoY.

05-05-2026

For the three months ended March 31, 2026, Ridgewood Energy U Fund LLC reported oil and gas revenue of $800 thousand, up 12% YoY from $712 thousand, driving net income to $388 thousand (+8% YoY) and income from operations to $355 thousand (+8% YoY). However, total expenses increased 16% YoY to $445 thousand, led by higher depletion and amortization (+20%) and operating expenses (+22%), while general and administrative expenses declined slightly; other income remained flat at $33 thousand. Operating cash flow strengthened significantly to $490 thousand (+119% YoY), though members' capital decreased to $4,656 thousand amid distributions.

• ·Proved oil and gas properties net: $2,280 thousand at March 31, 2026 (down from $2,519 thousand at Dec 31, 2025)
• ·Distributions in Q1 2026: $463 thousand (vs $197 thousand in Q1 2025)
• ·Shareholder net income interest: $307 thousand Q1 2026 (+7% YoY from $287 thousand)
• ·Cash and cash equivalents increased QoQ to $1,800 thousand from $1,780 thousand

05-05-2026

Enpro Inc. reported Q1 2026 net income of $27.4M, up 12% YoY from $24.5M, with diluted EPS increasing to $1.29 from $1.15; operating cash flow surged 89% to $39.6M. However, net cash decreased $35.5M due to $50.1M debt repayments, resulting in ending cash of $79.2M versus $240.3M YoY prior, and total assets dipped 1% QoQ to $2,635.5M. Long-term debt declined 8% QoQ to $605.2M, while shareholders' equity rose modestly 1% to $1,562.7M.

• ·Accounts receivable increased 22% QoQ to $163.8M from $134.1M.
• ·Inventories rose 3% QoQ to $158.7M from $153.8M.
• ·Other intangible assets decreased to $803.2M from $823.5M QoQ.
• ·Goodwill measurement period adjustment of $2.0M for SealingTechnologies.
• ·Pro forma net sales Q1 2025: $286.0M; pro forma net income: $24.0M.

05-05-2026

For the three months ended March 31, 2026, Ridgewood Energy X Fund, LLC reported oil and gas revenue of $800 thousand, up 12% YoY from $712 thousand, driving net income to $278 thousand (+15% YoY) and shareholder net income per share to $458 (+15% YoY). However, total expenses increased 11% YoY to $588 thousand, oil and gas properties net declined to $2,280 thousand from $2,519 thousand (QoQ), and total members' capital decreased slightly to $9,388 thousand. Operating cash flow improved sharply to $382 thousand from $148 thousand YoY.

• ·Depletion and amortization expense increased to $176 thousand from $139 thousand YoY.
• ·Management fees to affiliate decreased slightly to $162 thousand from $173 thousand YoY.
• ·Distributions totaled $383 thousand in Q1 2026 vs $312 thousand in Q1 2025.
• ·Cash and cash equivalents increased $18 thousand QoQ to $6,359 thousand.

05-05-2026

DuPont's net sales from continuing operations rose 4% YoY to $1,681 million in Q1 2026 from $1,612 million, driving income from continuing operations up 88% to $150 million, while operating cash flow from continuing operations surged 201% to $232 million. However, SG&A expenses increased 9% to $255 million, restructuring charges rose 18% to $46 million, and sundry income fell 64% to $36 million. Overall net income flipped to $164 million from a $581 million loss, aided by discontinued operations improving to a $14 million gain from a $661 million loss.

• ·Total assets decreased slightly to $21,449 million at March 31, 2026 from $21,575 million at December 31, 2025.
• ·Long-term debt stable at $3,132 million at March 31, 2026 vs. $3,134 million at December 31, 2025.
• ·Capital expenditures for continuing operations $102 million in Q1 2026, down from $122 million in Q1 2025.
• ·Dividends paid to stockholders $82 million in Q1 2026 ($0.20 per share) vs. $172 million in Q1 2025 ($0.41 per share).

05-05-2026

Ridgewood Energy Q Fund LLC reported total revenue of $365 thousand for Q1 2026, down 41.6% YoY from $625 thousand, driven by a 40.9% drop in oil and gas revenue to $325 thousand and 46.7% decline in other revenue to $40 thousand. Net income fell 36.7% to $133 thousand from $210 thousand, although total expenses decreased 40% to $264 thousand and interest income rose 28% to $32 thousand. Cash from operations plummeted 84.1% to $80 thousand, while shareholders' interest in net income declined to $97 thousand ($116 per share) from $145 thousand ($175 per share).

• ·Oil and gas properties, net: $1,891 thousand as of March 31, 2026 (up from $1,441 thousand at December 31, 2025).
• ·Total members' capital: $4,027 thousand as of March 31, 2026 (down from $4,087 thousand at December 31, 2025).
• ·Distributions: $193 thousand in Q1 2026 (down from $384 thousand in Q1 2025).
• ·Capital expenditures for oil and gas properties: $19 thousand in Q1 2026.